Navigation Links
Luminex Corporation Reports Third Quarter 2013 Results
Date:11/4/2013

eptance of Luminex's products and technology, the Company's dependence on strategic partners for development, commercialization and distribution of products, concentration of the Company's revenue in a limited number of strategic partners, fluctuations in quarterly results due to a lengthy and unpredictable sales cycle and bulk purchases of consumables, our ability to sell products directly to end users, our ability to satisfy market needs with products that we sell, Luminex's ability to scale manufacturing operations and manage operating expenses, gross margins and inventory levels, potential shortages of components, competition, the timing of regulatory approvals, the implementation, including any modification, of the Company's strategic operating plans, the uncertainty regarding the outcome or expense of any litigation brought against Luminex, risks relating to Luminex's foreign operations, risks and uncertainties associated with implementing our acquisition strategy and the ability to integrate acquired companies, or selected assets into our consolidated business operations, including the ability to recognize the benefits of our acquisitions, as well as the risks discussed under the heading "Risk Factors" in Luminex's Reports on Forms 10-K and 10-Q, as filed with the Securities and Exchange Commission.  The forward-looking statements, including the financial guidance and 2013 outlook, contained herein represent the judgment of Luminex as of the date of this press release, and Luminex expressly disclaims any intent, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in Luminex's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

Contacts:

Harriss T. CurrieSr. Vice President, Finance and Chief Financial Officer512-219-8020hcurrie@luminexcorp.com'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. LUMINEX CORPORATION TO HOST INVESTOR EVENT AT ASSOCIATION FOR MOLECULAR PATHOLOGY ANNUAL MEETING
2. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
3. Luminex Corporation Reports Second Quarter 2013 Results
4. Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
5. Luminex Corporation Second Quarter Earnings Release Scheduled for July 29, 2013
6. Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporations xMAP Technology
7. Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
8. Luminex Corporation To Present At Upcoming Investment Conferences
9. Luminex Corporation Reports First Quarter 2013 Results
10. Luminex Corporation First Quarter Earnings Release Scheduled for April 29, 2013
11. Luminex Corporation Reports Fourth Quarter And Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Does your doctor ... nearly 800 doctors have recommended marijuana to the over 112,000 ... 20. But the majority of the other roughly 20,300+ active ... know very little about it – even though a poll ... adults say they have tried it. ...
(Date:8/29/2014)... -- Diseases largely eradicated in the United ... was declared eliminated in 2000, yet the CDC reports ... highest incidence in 20 years. In July, ... a problem of "epidemic proportions." ... these preventable diseases—in part because some parents (more than ...
(Date:8/29/2014)... CITY, Calif. , Aug. 29, 2014  Abaxis, ... company manufacturing point-of-care blood instrumentation and consumables to the ... Clint Severson , Chairman and Chief Executive Officer, will ... Best Ideas Conference 2014 on Tuesday, September 9, 2014 ... at the Omni Berkshire Place Hotel in ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... as We Age, Becomes Squarer, Makes You Look Older, ... Your face,may be giving away your age, and it ... eyelids. A study in January,s Plastic and,Reconstructive Surgery(R) (PRS), ... Surgeons (ASPS), found that as we age, the,lower jaw ...
... Colo. and MONTREAL, Jan. 9 Pharmion,Corporation ... (TSX: MYG) today announced,the enrollment of the ... trial (Trial,CL002) evaluating MGCD0103, the Companies, isotype-selective ... with,Vidaza(R) (azacitidine for injection), Pharmion,s DNA demethylating ...
Cached Medicine Technology:Looking Older? How Square is Your Jaw Line? 2Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 2Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 3Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 4Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 5Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 6Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 7
(Date:8/31/2014)... (PRWEB) August 31, 2014 For many, fall ... likely the culprit. Ragweed is the most common cause of ... Americans. , The most common symptoms of ragweed allergy include ... and sneezing. Ragweed allergy can also lead to wheezing, asthma ... should consult an allergist about allergy immunotherapy - the only ...
(Date:8/31/2014)... With years of hard work, Delta has now become one ... the company has updated its wheel loader assortment ... these items are guaranteed to be great. Additionally, they are ... is true that all items in Delta’s used cat ... The firm is making full efforts to help worldwide customers ...
(Date:8/31/2014)... In the wake of growing consumer concerns ... to require mandatory labeling of GMOs on food and ... that affect their own health and the health of ... measures to eliminate GMOs from dietary supplements, NutriGold has ... initiative with the objective of advancing the non-GMO ...
(Date:8/31/2014)... 01, 2014 Top10BestSEOHosting.com, a reliable review ... and announces that FatCow, Arvixe and Hostgator are the ... plenty of ASP.NET hosting companies in the world, but ... complicated to run a reliable ASP.NET server than running ... skills. I firmly believe that FatCow, Arvixe and Hostgator ...
(Date:8/31/2014)... Ticket Down is a dependable source ... at the Sun Life Stadium in early September. Diehard soccer ... game on September 5th between Colombia and Brazil will likely set ... year between Brazil and Honduras at Sun Life Stadium brought in ... and has also been the home of the Florida Marlins of ...
Breaking Medicine News(10 mins):Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 2Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 3Health News:Delta Updates Its Wheel Loader Assortment With A Lot Of Cheap Used Cat 966 Loaders 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 3Health News:Best ASP.NET Hosting Award for August 2014 Released By Top10BestSEOHosting.com 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for September 5th Match 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for September 5th Match 3
... Whole genome sequencing spelling out a person,s entire ... being a medical option for direct patient care. Physicians ... Genomics Research Institute (TGen) successfully completed sequencing both a single ... of more than 6 billion DNA chemical bases. While ...
... patients were more likely to be readmitted to the hospital ... failure, or pneumonia, according to a new study from Harvard ... higher readmission rates were due to disparities related to both ... "Disparities in health and health care are well-documented in this ...
... Reporter , TUESDAY, Feb. 15 (HealthDay News) -- After ... older black people are more likely to be readmitted ... study finds. Overall, older blacks have 13 percent ... research suggests, while patients treated at hospitals that primarily ...
... two-thirds of California,s 7 million uninsured residents will become eligible ... in 2014, according to a new policy brief from the ... study draws on the latest data from the California Health ... The policy brief, "Two-thirds of California,s 7 Million Uninsured ...
... , TUESDAY, Feb. 15 (HealthDay News) -- Motorcycle helmets reduce ... a widely held belief that the weight of motorcycle helmets ... a popular myth that wearing a helmet while riding a ... Dr. Adil H. Haider, an assistant professor of surgery at ...
... HealthDay Reporter , TUESDAY, Feb. 15 (HealthDay News) ... women and men, with a few small but important differences, ... Each year, 55,000 more U.S. women than men suffer a ... One strong risk factor for stroke is atrial ...
Cached Medicine News:Health News:Whole genome sequencing used to help inform cancer therapy 2Health News:Whole genome sequencing used to help inform cancer therapy 3Health News:Study finds blacks more likely to be readmitted to hospitals after discharge 2Health News:Blacks Readmitted to Hospital More Than Whites: Study 2Health News:Blacks Readmitted to Hospital More Than Whites: Study 3Health News:4.7 million Californians to gain coverage under health reform, new study estimates 2Health News:4.7 million Californians to gain coverage under health reform, new study estimates 3Health News:Motorcycle Helmets Help Protect Against Spine Injury: Study 2Health News:Experts Issue New Heart Disease Guidelines for Women 2Health News:Experts Issue New Heart Disease Guidelines for Women 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: